HomeMarketsSharesTeijin Limited

Trade Teijin Limited - 3401 CFD

Market is not available at the momentMarket information is presented
as of 2026-10-05T06:05:37+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread3.7
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
¥1,000
Overnight funding adjustment
Charges from full value of position
-0.014438 %
(-¥3)

Trade size with leverage ~ ¥20,000

Money from leverage ~ $¥19,000


-0.01444%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
¥1,000
Overnight funding adjustment
Charges from full value of position
-0.007784 %
(-¥2)

Trade size with leverage ~ ¥20,000

Money from leverage ~ $¥19,000


-0.00778%
Overnight funding adjustment time21:00 (UTC)
CurrencyJPY
Min traded quantity1
Margin5.00%
Stock exchangeJapan
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close1631.4
Open1628.5
1-Year Change27.66%
Day's Range1625.8 - 1639.2

Trade Teijin Limited - 3401

About Teijin Ltd

TEIJIN LIMITED is a Japan-based company engaged in aramid, carbon fiber, resin, composite molding material, fiber, medicine, and information technology (IT) business. The Company operates in two business segments. The Materials segment is involved in the manufacture and sale of aramid fibers, carbon fibers, polycarbonate resins, polyester films, polyester fibers, textile products, and composite molding materials. The Healthcare segment is involved in the manufacture and sale of pharmaceuticals and medical devices, as well as the provision of home medical services. The Company is also engaged in IT related business, such as the operation and development of information systems, the maintenance and engineering business, as well as the design and sale of plants and equipment.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Teijin Ltd revenues increased 13% to Y687.01B. Net income decreased 4% to Y25.84B. Revenues reflect Material Business segment increase of 38% to Y284.55B, Health Care segment increase of 25% to Y139.56B, Other Businesses segment increase of 29% to Y16.15B. Net income was offset by Fiber Business segment income decrease of 72% to Y4.52B, Material Business segment loss increase from Y335M to Y4.8B.

Equity composition

FY'99-02 WAS were estimated. FY'04-'07 1&3Q WAS & o/s were estimated. FY'08 Q3 DWAS estimated and BWAS=O/S. FY'08 Q1 WAS=O/S. FY'11,12 Q1,12q2, 12 q3 DWAS is estimated. FY'11 Q3 DWAS was estimated.

Latest shares articles

BNP Paribas stock forecast
BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
7 hours ago
Boeing stock forecast
Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
8 hours ago
CaixaBank stock forecast
CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
9 hours ago
Valneva stock forecast
Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
12 hours ago

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready